Actualités et événements

Can simulations/modelling be patentable?

Simulations and modelling are core products across many industries, including energy, automotive, and AI. This drives a high volume of patent filings. However, their patentability is often unclear because Article …

Lire l'article

AI, Biotech and trade secrets

In this episode of HGF Presents, Amy Dawson and Jess Davis explore how artificial intelligence is opening new possibilities in the biotechnology sector and how trade secrets can be used …

Lire l'article

Case Law for Non-Reproducible Products as Prior Art

Does a non-reproducible commercially available product form part of the state of the art for a European patent application? This question was answered as “yes” in G 1/23 by the …

Lire l'article

Strategic Deployment of Third Party Observations

This episode outlines the strategic use of European Patent Office (EPO) pre-grant Third Party Observations (TPOs) It explains how TPOs can be used to influence the outcome of competitor patent …

Lire l'article

Inventive step

Overview: European patent applications are assessed for inventive step using the EPO’s structured problem–solution approach, which differs in important ways from other jurisdictions. This video explains how the EPO applies …

Lire l'article

Selection Inventions Sub Ranges

Overview: A sub-range falling within a previously disclosed broader range can form the basis for patentable claims in Europe, in accordance with the EPO’s assessment of selection inventions. This video …

Lire l'article

Multiple Claim Dependencies

Overview: US and European patent systems take different approaches to claim dependencies, and this difference can have significant consequences for prosecution and grant of patents. This video explains why US-style …

Lire l'article

Third party observations

Overview: Third Party Observations (TPOs) are a mechanism by which third parties can submit written observations in proceedings before the EPO. TPOs are often filed with the aim of persuading …

Lire l'article

Second Medical Use – Novelty of New Mechanism of Action

A newly discovered mode of action for a known compound can support patentable second medical use claims in Europe, even when the condition being treated is already known. This video …

Lire l'article